Don’t Jump to Nurtec ODT for Migraine Prevention in Adults

August 2021

Nurtec ODT (rimegepant) will now be used for migraine PREVENTION in adults...in addition to acute treatment.

It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.

Until recently, only the INJECTABLE CGRP antagonists (Aimovig, etc) were approved for prevention.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote